M. B. Koyuncu Et Al. , "Ruxolitinib Reduces Oxidative Stress in Patients With Primary Myelofibrosis: A Multicenter Study," CUREUS JOURNAL OF MEDICAL SCIENCE , vol.14, no.1, 2022
Koyuncu, M. B. Et Al. 2022. Ruxolitinib Reduces Oxidative Stress in Patients With Primary Myelofibrosis: A Multicenter Study. CUREUS JOURNAL OF MEDICAL SCIENCE , vol.14, no.1 .
Koyuncu, M. B., Ilgan, M., Basir, H., TOMBAK, A., Ucar, M. A., Koseci, T., ... AKDENİZ, A.(2022). Ruxolitinib Reduces Oxidative Stress in Patients With Primary Myelofibrosis: A Multicenter Study. CUREUS JOURNAL OF MEDICAL SCIENCE , vol.14, no.1.
Koyuncu, Mahmut Et Al. "Ruxolitinib Reduces Oxidative Stress in Patients With Primary Myelofibrosis: A Multicenter Study," CUREUS JOURNAL OF MEDICAL SCIENCE , vol.14, no.1, 2022
Koyuncu, Mahmut B. Et Al. "Ruxolitinib Reduces Oxidative Stress in Patients With Primary Myelofibrosis: A Multicenter Study." CUREUS JOURNAL OF MEDICAL SCIENCE , vol.14, no.1, 2022
Koyuncu, M. B. Et Al. (2022) . "Ruxolitinib Reduces Oxidative Stress in Patients With Primary Myelofibrosis: A Multicenter Study." CUREUS JOURNAL OF MEDICAL SCIENCE , vol.14, no.1.
@article{article, author={Mahmut B. Koyuncu Et Al. }, title={Ruxolitinib Reduces Oxidative Stress in Patients With Primary Myelofibrosis: A Multicenter Study}, journal={CUREUS JOURNAL OF MEDICAL SCIENCE}, year=2022}